Clinical Trial: An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07528235) titled 'An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH' on April 07.

Brief Summary: This is an open-label, dose-escalation study on the safety, tolerability and preliminary efficacy for preventing stroke-associated pneumonia of propranolol in patients with intracerebral hemorrhage. Propranolol is administered via intravenous pump continuously for 7 days.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Intracerebral Hemorrhage Stroke-Associated Pneumonia (SAP)

Intervention: DRUG: Intravenous Pump-...